Paola Citterio

Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

Stefano Rusconi, Simona La Seta Catamancio, Paola Citterio et al. · Antimicrobial Agents and Chemotherapy · 2000 · 91 citations · Full text

Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients

Daniela Mologni, Paola Citterio, Barbara Menzaghi et al. · AIDS · 2006 · 64 citations

Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections

Stefano Rusconi, Simona La Seta Catamancio, Paola Citterio et al. · Journal of Virology · 2000 · 27 citations · Full text

The Cost of HIV Disease in Northern Italy: The Payer's Perspective

Giuliano Rizzardini, Umberto Restelli, Paolo Bonfanti et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 26 citations

Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of <i>In Vitro</i> Lamivudine Drug Pressure

Stefano Rusconi, Maria Pia De Pasquale, Laura Milazzo et al. · Antiviral Therapy · 1998 · 19 citations